UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2013-10, Vol.24 Suppl 6, p.vi125-vi132

2013

Volltextzugriff (PDF)

Impact of age and medical comorbidity on adjuvant treatment outcomes for stage III colon cancer: a pooled analysis of individual patient data from four randomized, controlled trials

Annals of oncology, 2015-04, Vol.26 (4), p.715-724

2015

Volltextzugriff (PDF)

Effort myocardial ischemia during chemotherapy with 5-fluorouracil: an underestimated risk

Annals of oncology, 2014-05, Vol.25 (5), p.1059-1064

2014

Volltextzugriff (PDF)

Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries

Annals of oncology, 2012-04, Vol.23 (4), p.853-859

2012

Volltextzugriff (PDF)

Testicular seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2010-05, Vol.21 (suppl-5), p.v140-v146

2010

Volltextzugriff (PDF)

Pancreatic cancer treatment and research: an international expert panel discussion

Annals of oncology, 2011-07, Vol.22 (7), p.1500-1506

2011

Volltextzugriff (PDF)

A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours

Annals of oncology, 2005-07, Vol.16 (7), p.1152-1159

2005

Volltextzugriff (PDF)

Fluoropyrimidine (FP) + bevacizumab (BEV) + atezolizumab vs FP/BEV in BRAFwt metastatic colorectal cancer (mCRC): Findings from Cohort 2 of MODUL – a multicentre, randomized trial of biomarker-driven maintenance treatment following first-line induction therapy

Annals of oncology, 2018-10, Vol.29, p.viii714-viii715

2018

Volltextzugriff (PDF)

A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC 30974)

Annals of oncology, 2011-05, Vol.22 (5), p.1054-1061

2011

Volltextzugriff (PDF)

Quality of life assessment in patients with metastatic colorectal cancer receiving maintenance therapy after first-line induction treatment: a preplanned analysis of the phase III AIO KRK 0207 trial

Annals of oncology, 2016-12, Vol.27 (12), p.2203-2209

2016

Volltextzugriff (PDF)

Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy

British journal of cancer, 2013-04, Vol.108 (6), p.1316-1323

2013

Volltextzugriff (PDF)

Capecitabine/irinotecan or capecitabine/oxaliplatin in combination with bevacizumab is effective and safe as first-line therapy for metastatic colorectal cancer: a randomized phase II study of the AIO colorectal study group

Annals of oncology, 2013-06, Vol.24 (6), p.1580-1587

2013

Volltextzugriff (PDF)

The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008

Annals of oncology, 2009-06, Vol.20 (suppl-7), p.vii1-vii6

2009

Volltextzugriff (PDF)

Interdisciplinary care programme to improve self‐management for cancer patients undergoing stem cell transplantation: a prospective non‐randomised intervention study

European journal of cancer care, 2017-07, Vol.26 (4), p.e12458-n/a

2017

Volltextzugriff (PDF)

Quality assurance in the treatment of colorectal cancer: the EURECCA initiative

Annals of oncology, 2014-08, Vol.25 (8), p.1485-1492

2014

Volltextzugriff (PDF)

Extragonadal germ cell tumors

Annals of oncology, 2002-01, Vol.13 (suppl-4), p.265-272

SCHMOLL, H.-J

2002

Volltextzugriff (PDF)

Testicular non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2010-05, Vol.21 (suppl-5), p.v147-v154

2010

Volltextzugriff (PDF)

The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010

Annals of oncology, 2011-06, Vol.22, p.v1-v9

2011

Volltextzugriff (PDF)

Comparison of an aprepitant regimen with a multiple-day ondansetron regimen, both with dexamethasone, for antiemetic efficacy in high-dose cisplatin treatment

Annals of oncology, 2006-06, Vol.17 (6), p.1000-1006

2006

Volltextzugriff (PDF)

Analysis of OCT4 expression in an extended panel of human tumor cell lines from multiple entities and in human mesenchymal stem cells

Cellular and molecular life sciences : CMLS, 2009-02, Vol.66 (3), p.495-503

2009

Volltextzugriff (PDF)

Testicular seminoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Annals of oncology, 2009-05, Vol.20 (suppl-4), p.iv83-iv88

2009

Volltextzugriff (PDF)

Long-Term Results of First-Line Sequential High-Dose Etoposide, Ifosfamide, and Cisplatin Chemotherapy Plus Autologous Stem Cell Support for Patients With Advanced Metastatic Germ Cell Cancer: An Extended Phase I/II Study of the German Testicular Cancer Study Group

Journal of clinical oncology, 2003-11, Vol.21 (22), p.4083-4091

2003

Volltextzugriff (PDF)

The NK-1 receptor-antagonist aprepitant in high-dose chemotherapy (highdose melphalan and high-dose T-ICE: paclitaxel, ifosfamide, carboplatin, etoposide): efficacy and safety of a triple antiemetic combination

Bone marrow transplantation (Basingstoke), 2011-06, Vol.46 (6), p.784-789

2011

Volltextzugriff (PDF)

A meta-analysis comparing the efficacy of four 5-HT3-receptor antagonists for acute chemotherapy-induced emesis

Supportive care in cancer, 2007-09, Vol.15 (9), p.1023-1033

2007

Volltextzugriff (PDF)

1 – 25 von 643

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(538)
Mit Volltextzugriff
(488)

Publikationsform

Sprache

Englisch
(516)
Deutsch
(131)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(312)
Science & Technology
(270)
Life Sciences & Biomedicine
(268)
Oncology
(222)
Male
(194)
Biological And Medical Sciences
(168)
Medical Sciences
(165)
Adult
(119)
Pharmacology. Drug Treatments
(115)
Middle Aged
(108)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(106)
Female
(96)
Antineoplastic Agents
(95)
Chemotherapy
(92)
Tumors
(74)
Aged
(72)
Testicular Neoplasms - Drug Therapy
(60)
Combined Modality Therapy
(58)
Treatment Outcome
(50)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(44)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

Impact of age and medical comorbidity on adjuvant treatment outcomes for stage III colon cancer: a pooled analysis of individual patient data from four randomized, controlled trials

Effort myocardial ischemia during chemotherapy with 5-fluorouracil: an underestimated risk

Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries

Testicular seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Pancreatic cancer treatment and research: an international expert panel discussion

A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours

Fluoropyrimidine (FP) + bevacizumab (BEV) + atezolizumab vs FP/BEV in BRAFwt metastatic colorectal cancer (mCRC): Findings from Cohort 2 of MODUL – a multicentre, randomized trial of biomarker-driven maintenance treatment following first-line induction therapy

A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC 30974)

Quality of life assessment in patients with metastatic colorectal cancer receiving maintenance therapy after first-line induction treatment: a preplanned analysis of the phase III AIO KRK 0207 trial

Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy

Capecitabine/irinotecan or capecitabine/oxaliplatin in combination with bevacizumab is effective and safe as first-line therapy for metastatic colorectal cancer: a randomized phase II study of the AIO colorectal study group

The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008

Interdisciplinary care programme to improve self‐management for cancer patients undergoing stem cell transplantation: a prospective non‐randomised intervention study

Quality assurance in the treatment of colorectal cancer: the EURECCA initiative

Extragonadal germ cell tumors

Testicular non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010

Comparison of an aprepitant regimen with a multiple-day ondansetron regimen, both with dexamethasone, for antiemetic efficacy in high-dose cisplatin treatment

Analysis of OCT4 expression in an extended panel of human tumor cell lines from multiple entities and in human mesenchymal stem cells

Testicular seminoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Long-Term Results of First-Line Sequential High-Dose Etoposide, Ifosfamide, and Cisplatin Chemotherapy Plus Autologous Stem Cell Support for Patients With Advanced Metastatic Germ Cell Cancer: An Extended Phase I/II Study of the German Testicular Cancer Study Group

The NK-1 receptor-antagonist aprepitant in high-dose chemotherapy (highdose melphalan and high-dose T-ICE: paclitaxel, ifosfamide, carboplatin, etoposide): efficacy and safety of a triple antiemetic combination

A meta-analysis comparing the efficacy of four 5-HT3-receptor antagonists for acute chemotherapy-induced emesis

Suchergebnisse filtern